145 related articles for article (PubMed ID: 37789224)
1. Vascular endothelial growth factor antagonist peptides inhibit tumor growth and metastasis in breast cancer through repression of c-src and STAT3 genes.
Bejari M; Sasani ST; Asghari SM; Kolshan MN
Mol Biol Rep; 2023 Nov; 50(11):9213-9219. PubMed ID: 37789224
[TBL] [Abstract][Full Text] [Related]
2. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
3. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
[TBL] [Abstract][Full Text] [Related]
4. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
[TBL] [Abstract][Full Text] [Related]
5. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
6. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
Ganta VC; Choi M; Kutateladze A; Annex BH
Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
[TBL] [Abstract][Full Text] [Related]
7. MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling.
Du YE; Tu G; Yang G; Li G; Yang D; Lang L; Xi L; Sun K; Chen Y; Shu K; Liao H; Liu M; Hou Y
Theranostics; 2017; 7(16):3972-3988. PubMed ID: 29109792
[TBL] [Abstract][Full Text] [Related]
8. Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.
Farzaneh Behelgardi M; Zahri S; Gholami Shahvir Z; Mashayekhi F; Mirzanejad L; Asghari SM
Mol Biol Rep; 2020 Mar; 47(3):2061-2071. PubMed ID: 32072404
[TBL] [Abstract][Full Text] [Related]
9. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
10. A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.
Assareh E; Mehrnejad F; Mansouri K; Esmaeili Rastaghi AR; Naderi-Manesh H; Asghari SM
Biochem J; 2019 Feb; 476(4):645-663. PubMed ID: 30700502
[TBL] [Abstract][Full Text] [Related]
11. Asiatic acid inhibits angiogenesis and vascular permeability through the VEGF/VEGFR2 signaling pathway to inhibit the growth and metastasis of breast cancer in mice.
Tian M; Chen K; Huang J; Chu D; Li J; Huang K; Ma C
Phytother Res; 2021 Nov; 35(11):6389-6400. PubMed ID: 34541711
[TBL] [Abstract][Full Text] [Related]
12. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
[TBL] [Abstract][Full Text] [Related]
13. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice.
Gu JW; Young E; Busby B; Covington J; Johnson JW
Cancer Biol Ther; 2009 Mar; 8(6):514-21. PubMed ID: 19242105
[TBL] [Abstract][Full Text] [Related]
15. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
16. A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis.
Farzaneh Behelgardi M; Zahri S; Mashayekhi F; Mansouri K; Asghari SM
Sci Rep; 2018 Dec; 8(1):17924. PubMed ID: 30560942
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
20. Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.
Leong H; Mathur PS; Greene GL
Breast Cancer Res Treat; 2009 Oct; 117(3):505-15. PubMed ID: 18821062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
